Print

2019 RESEARCH

- Archives -

NIH administers first clinical trial treatment for GM1 gangliosidosis, a lysosomal storage disorder

NIH administers first clinical trial treatment for GM1 gangliosidosis, a lysosomal storage disorder

The first clinical trial of a gene therapy treatment based on discoveries made by UMass Medical School and Auburn University researchers has been administered in a child at the National Institutes of Health. UMMS researchers Heather Gray Edwards, PhD, DVM, and Miguel Sena-Esteves, PhD, collaborated with colleagues at Auburn University on the research.

David McManus developing mobile health component for RURAL health study of disease risk factors

David McManus developing mobile health component for RURAL health study of disease risk factors

UMass Medical School physician-scientist David McManus is the primary investigator of the mobile health core of the RURAL study, which seeks to understand why people born in rural communities in the South live shorter and less healthy lives than their counterparts elsewhere in the country.

UMass Medical School awards grants to advance commercialization of research discoveries

UMass Medical School awards grants to advance commercialization of research discoveries

UMass Medical School has awarded the first BRIDGE Fund grants to support innovative translational research. The first recipients of funding are Jie Song, PhD, and Timothy Kowalik, PhD.

Ellen Gravallese awarded Nachman Prize for research in rheumatology

Ellen Gravallese awarded Nachman Prize for research in rheumatology

UMass Medical School physician-scientist Ellen M. Gravallese, MD, received the Carol Nachman Prize for Rheumatology, an international honor for research in rheumatology, from city dignitaries at a ceremony in Wiesbaden, Germany.

Potential drug targets for ALS and FTD identified in two Fen-Biao Gao studies

Potential drug targets for ALS and FTD identified in two Fen-Biao Gao studies

A pair of collaborative studies led by Fen-Biao Gao, PhD, have identified two potential drug targets for the diseases amyotrophic lateral sclerosis and frontotemporal dementia. The studies provide a new layer of detail about how the most common genetic mutation responsible for both ALS and FTD causes neuron cell death.

Amir Mitchell lab engages high school classes in superbug research via online portal

Amir Mitchell lab engages high school classes in superbug research via online portal

Under the guidance of Amir Mitchell, PhD, 250 high school students from Massachusetts, California and Israel have had the opportunity to research one of medicine’s biggest challenges today—the emergence of superbugs.

New research reveals link between mental health and pediatric suicide by firearm

New research reveals link between mental health and pediatric suicide by firearm

A new study by UMass Medical School researchers finds hospitals across the United States are seeing a trend in children and young adults being hospitalized as a result of self-inflicted wounds from guns. Robert McLoughlin, MD, is first author on the study.

The Angel Fund contributes $1.1 million for ALS research at UMass Medical School

The Angel Fund contributes $1.1 million for ALS research at UMass Medical School

The Angel Fund for ALS Research has delivered on its pledge to donate an additional $1 million in support of ALS research underway at UMass Medical School.

Beth McCormick, John Haran explore link between microbiome and Alzheimer’s disease

Beth McCormick, John Haran explore link between microbiome and Alzheimer’s disease

In a new study, Beth A. McCormick, PhD, and John P. Haran, MD, PhD, show that patients with Alzheimer’s disease have distinctly different microbiomes than patients with other forms of dementia, establishing a critical bridge connecting specific bacteria species and different types of dementia prevalent in the elderly.

LISTEN: How wearable technology could help to stem opioid crisis

LISTEN: How wearable technology could help to stem opioid crisis

In a new Voices of UMassMed podcast, Stephanie Carreiro, MD, discusses ongoing research into how wearable technology has the potential to help prevent opioid-use disorder and treat patients in recovery.

Showing 1-10 of 50 items
of 5